Oncotelic Therapeutics (OTLC) Cash from Financing Activities (2010 - 2025)
Oncotelic Therapeutics' Cash from Financing Activities came in at $462,874 for Q4 2025, compared with $41,000 a year earlier and down 26.3% from the prior quarter.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Cash from Financing Activities (2010 - 2025) Analysis & Trends
For FY2025, Oncotelic Therapeutics' Cash from Financing Activities was $1.39 million, up 111.3% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of -15.5% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $656,000 in FY2024 (-47.5%), $1.25 million in FY2023 (+11.1%), $1.13 million in FY2022 (-75.2%) and $4.53 million in FY2021 (+40.5%).
- The five-year range for quarterly Cash from Financing Activities is $41,000 (Q4 2024) to $1.61 million (Q1 2021).
- Year-over-year, Cash from Financing Activities increased in two of the last seven quarters, with an average decline of 2.7%.
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q3 2023 (growth of 456.5%), and the weakest in Q4 2022 (a decline of 95.6%).
- Business Quant data shows OTLC's Cash from Financing Activities at $628,000 (Q3 2025), $135,000 (Q2 2025) and $160,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 462,874.00 |
| Sep 30, 2025 | 628,000.00 |
| Jun 30, 2025 | 135,000.00 |
| Mar 31, 2025 | 160,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 220,000.00 |
| Jun 30, 2024 | 145,000.00 |
| Mar 31, 2024 | 250,000.00 |
| Dec 31, 2023 | 275,000.00 |
| Sep 30, 2023 | 335,000.00 |
| Jun 30, 2023 | 440,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 68,250.00 |
| Sep 30, 2022 | 60,193.00 |
| Jun 30, 2022 | 504,997.00 |
| Mar 31, 2022 | 491,805.00 |
| Dec 31, 2021 | 1.56 Mn |
| Sep 30, 2021 | 517,481.00 |
| Jun 30, 2021 | 844,983.00 |
| Mar 31, 2021 | 1.61 Mn |
API Access
Oncotelic Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();